Pharmacokinetics Of Terbinafine: Absorption, Distribution, And Elimination Explained

Terbinafine is an antifungal medication widely used to treat fungal infections of the skin and nails. Understanding its pharmacokinetics — how the drug is absorbed, distributed, and eliminated — is essential for optimizing treatment and ensuring patient safety.

Absorption of Terbinafine

Terbinafine is administered orally in the form of tablets. It is well absorbed from the gastrointestinal tract, with bioavailability reaching approximately 40-50%. Food intake can influence absorption, often increasing the extent of absorption but also delaying the time to reach peak plasma concentrations.

Factors Affecting Absorption

  • Presence of food in the stomach
  • Gastrointestinal pH levels
  • Formulation of the medication

Once absorbed, terbinafine quickly enters the bloodstream, initiating its distribution to tissues.

Distribution of Terbinafine

Terbinafine exhibits extensive tissue distribution, particularly accumulating in keratinized tissues like skin, hair, and nails. Its high lipophilicity allows it to penetrate cell membranes effectively, leading to high concentrations in these tissues.

In plasma, terbinafine binds strongly to plasma proteins, mainly albumin, which influences its distribution and free active concentration.

Distribution Kinetics

  • Rapid initial distribution phase
  • High affinity for skin and nails
  • Prolonged retention in keratinized tissues

This tissue affinity explains the drug’s long half-life and the need for prolonged treatment courses to ensure complete eradication of fungal infections.

Elimination of Terbinafine

Terbinafine is primarily eliminated through hepatic metabolism. The liver enzymes metabolize the drug into inactive metabolites, which are then excreted via urine and feces.

Metabolism and Excretion

  • Extensive first-pass metabolism in the liver
  • Metabolized mainly by cytochrome P450 enzymes
  • Elimination half-life ranges from 17 to 32 hours

The prolonged half-life supports once-daily dosing and allows for accumulation in tissues, maintaining therapeutic levels over time.

Factors Influencing Pharmacokinetics

Several factors can affect how terbinafine is processed in the body, including liver function, age, and concurrent medications. Impaired liver function can reduce metabolism, leading to increased plasma levels and potential toxicity.

Understanding these pharmacokinetic principles helps clinicians tailor dosing regimens, monitor for adverse effects, and ensure effective treatment outcomes.